JP2015524812A5 - - Google Patents

Download PDF

Info

Publication number
JP2015524812A5
JP2015524812A5 JP2015524470A JP2015524470A JP2015524812A5 JP 2015524812 A5 JP2015524812 A5 JP 2015524812A5 JP 2015524470 A JP2015524470 A JP 2015524470A JP 2015524470 A JP2015524470 A JP 2015524470A JP 2015524812 A5 JP2015524812 A5 JP 2015524812A5
Authority
JP
Japan
Prior art keywords
cis
trifluoromethyl
naphthalen
oxy
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015524470A
Other languages
English (en)
Japanese (ja)
Other versions
JP6391571B2 (ja
JP2015524812A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/052316 external-priority patent/WO2014018881A1/en
Publication of JP2015524812A publication Critical patent/JP2015524812A/ja
Publication of JP2015524812A5 publication Critical patent/JP2015524812A5/ja
Application granted granted Critical
Publication of JP6391571B2 publication Critical patent/JP6391571B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015524470A 2012-07-27 2013-07-26 Atx調節剤 Expired - Fee Related JP6391571B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261676705P 2012-07-27 2012-07-27
US61/676,705 2012-07-27
PCT/US2013/052316 WO2014018881A1 (en) 2012-07-27 2013-07-26 Atx modulating agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018088836A Division JP2018135379A (ja) 2012-07-27 2018-05-02 Atx調節剤

Publications (3)

Publication Number Publication Date
JP2015524812A JP2015524812A (ja) 2015-08-27
JP2015524812A5 true JP2015524812A5 (https=) 2016-09-08
JP6391571B2 JP6391571B2 (ja) 2018-09-19

Family

ID=49997862

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015524470A Expired - Fee Related JP6391571B2 (ja) 2012-07-27 2013-07-26 Atx調節剤
JP2018088836A Pending JP2018135379A (ja) 2012-07-27 2018-05-02 Atx調節剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018088836A Pending JP2018135379A (ja) 2012-07-27 2018-05-02 Atx調節剤

Country Status (22)

Country Link
US (2) US9522889B2 (https=)
EP (1) EP2877166B1 (https=)
JP (2) JP6391571B2 (https=)
KR (1) KR102127026B1 (https=)
CN (1) CN104768541B (https=)
AR (1) AR091930A1 (https=)
AU (1) AU2013295584B2 (https=)
BR (1) BR112015001759A8 (https=)
CA (1) CA2879360C (https=)
CL (1) CL2015000209A1 (https=)
CO (1) CO7350623A2 (https=)
DK (1) DK2877166T3 (https=)
EA (1) EA028364B1 (https=)
ES (1) ES2668694T3 (https=)
IL (1) IL236693B (https=)
MX (1) MX363388B (https=)
MY (1) MY171486A (https=)
NZ (1) NZ703852A (https=)
PH (1) PH12015500181B1 (https=)
SG (1) SG11201500339XA (https=)
TW (1) TWI616430B (https=)
WO (1) WO2014018881A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2014DN09346A (https=) 2012-06-13 2015-07-17 Hoffmann La Roche
MX363388B (es) * 2012-07-27 2019-03-20 Biogen Ma Inc Agentes moduladores de autotaxina.
EA027809B1 (ru) 2012-07-27 2017-09-29 Биоген Айдек Ма Инк. Соединения, которые являются s1p-модулирующими агентами и/или atx-модулирующими агентами
US9555050B2 (en) 2012-07-27 2017-01-31 Biogen Ma Inc. ATX modulating agents
WO2014025709A1 (en) 2012-08-06 2014-02-13 Biogen Idec Ma Inc. Compounds that are s1p modulating agents and/or atx modulating agents
WO2014025708A1 (en) 2012-08-06 2014-02-13 Biogen Idec Ma Inc. Compounds that are s1p modulating agents and/or atx modulating agents
KR102179599B1 (ko) 2012-09-25 2020-11-19 에프. 호프만-라 로슈 아게 이환형 유도체
AR095079A1 (es) 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
CN105764905B (zh) 2013-11-26 2019-06-07 豪夫迈·罗氏有限公司 新的八氢-环丁二烯并[1,2-c;3,4-c’]二吡咯-2基
CN106103446B (zh) 2014-03-26 2019-07-30 豪夫迈·罗氏有限公司 作为自分泌运动因子(atx)和溶血磷脂酸(lpa)生产抑制剂的二环化合物
WO2015144609A1 (en) 2014-03-26 2015-10-01 F. Hoffmann-La Roche Ag Condensed [1,4]diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors
GB201501870D0 (en) 2015-02-04 2015-03-18 Cancer Rec Tech Ltd Autotaxin inhibitors
GB201502020D0 (en) 2015-02-06 2015-03-25 Cancer Rec Tech Ltd Autotaxin inhibitory compounds
MA41898A (fr) 2015-04-10 2018-02-13 Hoffmann La Roche Dérivés de quinazolinone bicyclique
AU2016270373A1 (en) 2015-06-05 2018-01-04 Vertex Pharmaceuticals Incorporated Triazoles for the treatment of demyelinating diseases
CA2992889A1 (en) 2015-09-04 2017-03-09 F. Hoffmann-La Roche Ag Phenoxymethyl derivatives
RU2018112230A (ru) 2015-09-24 2019-10-30 Ф. Хоффманн-Ля Рош Аг Бициклические соединения в качестве ингибиторов atx
CR20180057A (es) 2015-09-24 2018-04-02 Hoffmann La Roche Nuevos compuestos biciclicos como inhibidores duales de atx/ca.
KR20180054830A (ko) 2015-09-24 2018-05-24 에프. 호프만-라 로슈 아게 오토탁신(atx) 억제제로서의 이환형 화합물
AU2016328365B2 (en) 2015-09-24 2020-04-23 F. Hoffmann-La Roche Ag New bicyclic compounds as dual ATX/CA inhibitors
WO2018106646A1 (en) 2016-12-06 2018-06-14 Vertex Pharmaceuticals Incorporated Aminotriazoles for the treatment of demyelinating diseases
WO2018106641A1 (en) 2016-12-06 2018-06-14 Vertex Pharmaceuticals Incorporated Pyrazoles for the treatment of demyelinating diseases
WO2018106643A1 (en) 2016-12-06 2018-06-14 Vertex Pharmaceuticals Incorporated Heterocyclic azoles for the treatment of demyelinating diseases
SG11201908560SA (en) 2017-03-16 2019-10-30 Hoffmann La Roche Heterocyclic compounds useful as dual atx/ca inhibitors
WO2018167113A1 (en) 2017-03-16 2018-09-20 F. Hoffmann-La Roche Ag New bicyclic compounds as atx inhibitors
EP3638672A1 (en) 2017-06-13 2020-04-22 GlaxoSmithKline Intellectual Property Development Limited Chemical compounds as h-pgds inhibitors
WO2020156459A1 (zh) 2019-02-01 2020-08-06 湖北生物医药产业技术研究院有限公司 吡咯并嘧啶衍生物及其用途

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US5219837A (en) 1990-06-21 1993-06-15 Trustees Of The University Of Pennsylvania Method of stimulating myelination of cells
IL135495A (en) 1995-09-28 2002-12-01 Hoechst Ag Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid
CN1703403A (zh) * 2000-10-02 2005-11-30 詹森药业有限公司 趋代谢的谷氨酸盐受体拮抗剂
CN1642580B (zh) 2002-03-29 2010-05-26 詹森药业有限公司 放射性标记的喹啉和喹啉酮衍生物及其作为代谢性谷氨酸受体配体的制造用途
CA2528232C (en) * 2003-06-06 2010-05-25 Fibrogen, Inc. Novel nitrogen-containing heteroaryl compounds and their use in increasing endogenous erythropoietin
JP4932495B2 (ja) 2004-01-23 2012-05-16 アムゲン インコーポレイテッド 化合物及び使用方法
EP2592066B1 (en) * 2004-12-13 2014-12-03 Ono Pharmaceutical Co., Ltd. Aminocarboxylic acid derivative and medical use thereof
CN101365682A (zh) * 2005-12-08 2009-02-11 千禧药品公司 具有激酶抑制活性的双环化合物
EP2476669A1 (en) * 2006-01-27 2012-07-18 Fibrogen, Inc. Cyanoisoquinoline compounds and methods of use thereof
CA2651072A1 (en) * 2006-05-01 2007-11-08 Pfizer Products Inc. Substituted 2-amino-fused heterocyclic compounds
JP2010536791A (ja) * 2007-08-15 2010-12-02 ユニバーシティ オブ バージニア パテント ファンデーション 二環式スフィンゴシン1−リン酸アナログ
ES2613739T3 (es) * 2008-10-30 2017-05-25 Biogen Ma Inc. Análogos heterobicíclicos de 1-fosfato de esfingosina
US8269043B2 (en) 2008-10-30 2012-09-18 Biogen Idec Ma Inc. Bicyclic aryl sphingosine 1-phosphate analogs
MX2011008450A (es) * 2009-02-10 2011-09-01 Abbott Lab Agonistas y antagonistas del receptor s1p5, y metodos de uso de los mismos.
UA107360C2 (en) * 2009-08-05 2014-12-25 Biogen Idec Inc Bicyclic aryl sphingosine 1-phosphate analogs
EP2575794A2 (en) 2010-06-04 2013-04-10 B.S.R.C. "Alexander Fleming" Autotaxin pathway modulation and uses thereof
UA113507C2 (xx) * 2011-02-07 2017-02-10 Модулятори s1p
WO2012107500A1 (en) * 2011-02-10 2012-08-16 Novartis Ag [1, 2, 4] triazolo [4, 3 -b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
US9555050B2 (en) * 2012-07-27 2017-01-31 Biogen Ma Inc. ATX modulating agents
MX363388B (es) * 2012-07-27 2019-03-20 Biogen Ma Inc Agentes moduladores de autotaxina.
EA027809B1 (ru) * 2012-07-27 2017-09-29 Биоген Айдек Ма Инк. Соединения, которые являются s1p-модулирующими агентами и/или atx-модулирующими агентами
WO2014025709A1 (en) * 2012-08-06 2014-02-13 Biogen Idec Ma Inc. Compounds that are s1p modulating agents and/or atx modulating agents
WO2014025708A1 (en) * 2012-08-06 2014-02-13 Biogen Idec Ma Inc. Compounds that are s1p modulating agents and/or atx modulating agents
AR092253A1 (es) * 2012-08-27 2015-04-08 Array Biopharma Inc Inhibidores de serina/treonina cinasa
WO2014081756A1 (en) * 2012-11-20 2014-05-30 Biogen Idec Ma Inc. S1p and/or atx modulating agents
CA2899322A1 (en) * 2013-01-29 2014-08-07 Biogen Ma Inc. S1p modulating agents

Similar Documents

Publication Publication Date Title
JP2015524812A5 (https=)
US11129834B2 (en) Combinations and methods comprising a capsid assembly inhibitor
AR083933A1 (es) Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak
RU2015108898A (ru) 3-ЦИКЛОГЕКСЕНИЛ И ЦИКЛОГЕКСИЛ ЗАМЕЩЕННЫЕ ИНДОЛЬНЫЕ И ИНДАЗОЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ RORгаммаТ И ИХ ПРИМЕНЕНИЯ
RU2321588C2 (ru) Карбаматные производные хинуклидина, фармацевтическая композиция на их основе и применение
JP2014505696A5 (https=)
MA27475A1 (fr) Composes de pyrazolo [3,4-b] pyridine et leur utilisation en tant qu'inhibiteurs de phosphodiesterase
RU2012103487A (ru) Ингибирующие jak соединения на основе пиразолопиримидина и способы
JP2013523889A5 (https=)
NZ592685A (en) Modulators of cystic fibrosis transmembrane conductance regulator
JP2013209405A5 (https=)
RU2015102531A (ru) Офтальмологический состав и способ для облегчения пресбиопии
JP2016525078A (ja) ブロモドメイン阻害剤としての新規の置換された二環式化合物
SI3004106T1 (en) Dual selective PI3 delta and gamma inhibitors
RU2013105444A (ru) Конденсированные гетероциклические производные в качестве модуляторов s1p
TW201811733A (zh) 稠合三環γ-胺基酸衍生物、其製備方法及其在醫藥上的應用
JP2013542261A5 (https=)
JP2011500621A5 (https=)
JP2011511089A5 (https=)
WO2017176962A1 (en) Pyrrolo[1,2-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
RU2017133660A (ru) Новые гетероциклические соединения и их применение в профилактике или лечении бактериальных инфекций
RU2013153898A (ru) Новые гексагидроциклопентапирролоны, гексагидропирролопирролоны, октагидропирролопиридиноны и октагидропиридиноны
RU2012128859A (ru) Ингибиторы цистеиновой протеазы
RU2012141061A (ru) Агонист рецептора грелина для лечения кахексии
US20220047594A1 (en) Method for treating interstitial lung disease